Advanced search
1 file | 800.24 KB

Future avenues to decrease uremic toxin concentration

Raymond Vanholder (UGent) , Sunny Eloot (UGent) and Griet Glorieux (UGent)
Author
Organization
Keywords
TUBULAR EPITHELIAL-CELLS, HIGH-FLUX HEMODIALYSIS, RANDOMIZED CONTROLLED-TRIALS, POSTDILUTION ONLINE HEMODIAFILTRATION, residual kidney function, FRACTIONATED PLASMA SEPARATION, CHRONIC-RENAL-FAILURE, PROTEIN-BOUND SOLUTES, P-CRESYL SULFATE, review, microbiome, kidney failure, intestinal generation, end-stage renal disease (ESRD), hemodialysis, dialysis adequacy, Uremic toxins, dialysate, CHRONIC KIDNEY-DISEASE, uremic toxin removal, ALL-CAUSE MORTALITY

Downloads

  • (...).pdf
    • full text
    • |
    • UGent only
    • |
    • PDF
    • |
    • 800.24 KB

Citation

Please use this url to cite or link to this publication:

Chicago
Vanholder, Raymond, Sunny Eloot, and Griet Glorieux. 2016. “Future Avenues to Decrease Uremic Toxin Concentration.” American Journal of Kidney Diseases 67 (4): 664–676.
APA
Vanholder, R., Eloot, S., & Glorieux, G. (2016). Future avenues to decrease uremic toxin concentration. AMERICAN JOURNAL OF KIDNEY DISEASES, 67(4), 664–676.
Vancouver
1.
Vanholder R, Eloot S, Glorieux G. Future avenues to decrease uremic toxin concentration. AMERICAN JOURNAL OF KIDNEY DISEASES. 2016;67(4):664–76.
MLA
Vanholder, Raymond, Sunny Eloot, and Griet Glorieux. “Future Avenues to Decrease Uremic Toxin Concentration.” AMERICAN JOURNAL OF KIDNEY DISEASES 67.4 (2016): 664–676. Print.
@article{7096995,
  author       = {Vanholder, Raymond and Eloot, Sunny and Glorieux, Griet},
  issn         = {0272-6386},
  journal      = {AMERICAN JOURNAL OF KIDNEY DISEASES},
  language     = {eng},
  number       = {4},
  pages        = {664--676},
  title        = {Future avenues to decrease uremic toxin concentration},
  url          = {http://dx.doi.org/10.1053/j.ajkd.2015.08.029},
  volume       = {67},
  year         = {2016},
}

Altmetric
View in Altmetric
Web of Science
Times cited: